Skip to content
Fencer Intel
critical 9.9

CVE-2026-34037 json

Cross-Tenant Resource Cloning via Broken Object-Level Authorization in cloneTo()

published 4mo ago modified 15d ago also EUVD-2026-41996

cvss
9.9
version 3.1, CNA
cisa kev
Not listed
not in CISA's catalog
epss
0.4%
EPSS 0.4% chance of exploitation in 30 days, percentile 31%
public exploits
0
none known

Summary

Coolify is an open-source and self-hostable tool for managing servers, applications, and databases. Prior to 4.0.0-beta.464, the cloneTo() Livewire action in ResourceOperations.php authorizes the source resource but resolves destination resources with unscoped Eloquent lookups, allowing an authenticated user to clone resources into destinations owned by other teams and access cross-tenant resources. This issue is fixed in version 4.0.0-beta.464.

Patch / fix

  • coollabs coolify 4.0.0-beta.464

Is CVE-2026-34037 in your stack? Fencer shows which of your repositories are affected as soon as an advisory lands, and opens the fix as a pull request.

Check with Fencer

CISA SSVC

Exploitation
Proof of concept is public
Automatable
no
Technical impact
partial
Assessed
4mo ago

Exploit prediction

0.37% chance of exploitation in the next 30 days, higher than 31% of all scored CVEs (FIRST EPSS, 2026-11-09).

Exploits and checks

  • github.com https://github.com/coollabsio/coolify/security/advisories/GHSA-ggrr-wrvr-x83v referenced PoC, tagged "exploit" by a source, unverified

CVSS scores

assigned by version score vector
CNA 3.1 9.9 CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:L

Affected products

  • coollabsio coolify

Classification

Weakness
  • CWE-639 Authorization Bypass Through User-Controlled Key

References

Sources

Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.

CPEs and fixed versions use Anchore's correction of NVD's data: Added CPE configurations because not yet analyzed by NVD.